MedPath

Physical Performance of Women at Different Stages of the Menstrual Cycle, and Photobiomodulation Therapy

Not Applicable
Completed
Conditions
Menstrual Cycle Disorder
Interventions
Device: Photobiomodulation
Registration Number
NCT04281446
Lead Sponsor
University of Sao Paulo
Brief Summary

Hormonal fluctuations present during the ovarian cycle may have a strong influence on physiological and psychological aspects on physical performance in women. The aspects surrounding performance and ovarian cycles in women during different phases of the cycle, are still current and should be debated in the literature, as the available evidence has conflicting results. In addition to the above, new ergogenic methods have been studied to improve the sports scenario in different populations. Research on the use of ergogenic electrophysical resources so that hormonal effects may possibly be mitigated, allowing women to use this resource and improving their physical performance is still scarce in the current literature.

Detailed Description

Objective: To evaluate the physical performance of women during different phases of the ovarian cycle and the influence of photobiomodulation therapy in this setting. Methods: The research will be conducted in two subprojects - Subproject I is a cross-sectional study. Initially the participants will be evaluated in two phases separately, being the first and second day within the ovarian cycle in the follicular phase (FF) and the third and fourth day in the luteal phase (FL). The aspects of body composition, body water volume and skin temperature by infrared thermography will be evaluated, and the physical performance evaluation will be constituted by the evaluation of the muscular performance by isokinetic dynamometer, and by a treadmill supramaximal effort test. , together with analysis of VO2max and blood lactate levels. Subproject II is a double-blind placebo-controlled randomized clinical trial. After completion of subproject I, during the next ovarian cycle within the participants will return to conduct the second part of the study, which will analyze the influence of photobiomodulation therapy on the physical performance of women within their menstrual cycle, related to low hormone rate ( FF). 200 J of energy will be applied before each evaluation, which is muscle performance and endurance. The tests will be performed in the same order, following the same protocol in both phases of the study. For data analysis, a normality test will be used to verify the distribution and statistical tests consistent with the appropriate intra and intergroup comparisons, being considered two factors in the comparisons, time and group. A significance level of 5% will be adopted. The effect size will be calculated by Cohens'd.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
27
Inclusion Criteria
  • Women
  • 18 to 35 years
  • Healthy
  • Physically Active (150 min / week)
Exclusion Criteria
  • Eating disorders;
  • Hormonal disorders;
  • Amenorrhea;
  • Pregnancy;
  • Polycystic ovary;
  • Endometriosis;
  • Tumors;
  • Musculoskeletal injury in the last 6 months;
  • Cardiorespiratory disease;
  • Use of alcohol and illegal drugs during the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
G - Sham - CENPhotobiomodulationSham Photobiomodulation (disabled) application in women of endogenous cycle. The procedure and equipment will be the same as for the experimental groups, however no dosage will be applied: Antares® equipment (IBRAMED, Amparo-SP, Brazil) will be used, by means of a cluster, with two wavelengths (13 LEDs of 630 nm, 300 mW + 13 LEDs of 850 nm, 500 mW), being its area of 80 cm² contact, with 0 J of energy being applied at 15 points on each thigh - 9 in the anterior region and 6 in the posterior region, in addition to 2 points in the gastrocnemius.
G-FBM-CENPhotobiomodulationPhotobiomodulation application in women of endogenous cycle. Antares® equipment (IBRAMED, Amparo-SP, Brazil) will be used, by means of a cluster, with two wavelengths (13 LEDs of 630 nm, 300 mW + 13 LEDs of 850 nm, 500 mW), being its area of 80 cm² contact, acting 180 J of energy being applied at 15 points on each thigh - 9 in the anterior region and 6 in the posterior region, in addition to 2 points in the gastrocnemius.
Primary Outcome Measures
NameTimeMethod
Fatigue Strength20 minutes

Distance traveled during incremental testing (km)

Secondary Outcome Measures
NameTimeMethod
Body Temperature15 minutes

Thermographic evaluation (°C)

Muscle Performance20 minutes

Quantitative assessment of muscle performance performed by isokinetic dynamometer (N/m; W, %)

Subjective Perception of Effort20 minutes

Modified 10-point Borg scale

The scale assesses the level of effort, with 0 being no effort and 10 being the maximum physical effort.

Ventilatory variables20 minutes

VO2máx (ml.kg-1.min-1)

Lactate20 minutes

Lactate threshold (iLL) and anaerobic threshold (iLAN) (mmol/L)

Body water level10 minutes

Bioimpedance Evaluation (%)

Trial Locations

Locations (2)

Universidade de São Paulo

🇧🇷

Ribeirão Preto, São Paulo, Brazil

Rinaldo Roberto de Jesus Guirro

🇧🇷

Ribeirão Preto, SP, Brazil

© Copyright 2025. All Rights Reserved by MedPath